Effect of chronic desipramine treatment on neurotransmitter-thyrotropin releasing hormone - thyrotropin interactions in the rat
dc.contributor.author | Jaffer A. | |
dc.contributor.author | Russell V.A. | |
dc.contributor.author | Taljaard J.J.F. | |
dc.date.accessioned | 2011-05-15T16:17:28Z | |
dc.date.available | 2011-05-15T16:17:28Z | |
dc.date.issued | 1987 | |
dc.description.abstract | Long-term administration of the antidepressant drug, desipramine (20 mg/kg/day, orally for 28 days), decreased the stimulatory effect of the α2-adrenoceptor agonist, clonidine (250 μg/kg, i.p.) on thyrotropin (TSH) secretion in the rat, but did not alter basal TSH secretion. β-Adrenoceptor-mediated inhibition of TSH secretion by isoproterenol (1 mg/kg, i.p.) was unaffected by chronic desipramine treatment, as were the stimulatory effect of TSH-releasing hormone (TRH, 5 μg/kg, i.v.) on TSH release and its inhibition by the α-adrenoceptor antagonist, phentolamine (2 mg/kg, i.p.). These findings suggest that chronic desipramine treatment induces subsensitivity of α2-adrenoceptors which modulate TSH secretion in the rat while not affecting β2-adrenoceptor-mediated inhibition of TSH release. These findings suggest that pituitary TRH receptors are unchanged but that changes occurred at the hypothalamic level in α2-adrenoceptor-mediated stimulation of TRH release. Although cerebral β-adrenoceptors have been shown convincingly to be down-regulated after chronic desipramine treatment, their function in the hypothalamic TRH system after 28 days of treatment with desipramine appears to be unimpaired. | |
dc.description.version | Article | |
dc.identifier.citation | Neurochemical Research | |
dc.identifier.citation | 12 | |
dc.identifier.citation | 11 | |
dc.identifier.issn | 03643190 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/14234 | |
dc.subject | clonidine | |
dc.subject | desipramine | |
dc.subject | isoprenaline | |
dc.subject | phentolamine | |
dc.subject | protirelin | |
dc.subject | thyrotropin | |
dc.subject | adverse drug reaction | |
dc.subject | animal experiment | |
dc.subject | central nervous system | |
dc.subject | nonhuman | |
dc.subject | oral drug administration | |
dc.subject | rat | |
dc.subject | Animal | |
dc.subject | Clonidine | |
dc.subject | Desipramine | |
dc.subject | Drug Interactions | |
dc.subject | Isoproterenol | |
dc.subject | Male | |
dc.subject | Phentolamine | |
dc.subject | Protirelin | |
dc.subject | Rats | |
dc.subject | Rats, Inbred Strains | |
dc.subject | Receptors, Adrenergic | |
dc.subject | Support, Non-U.S. Gov't | |
dc.subject | Thyrotropin | |
dc.title | Effect of chronic desipramine treatment on neurotransmitter-thyrotropin releasing hormone - thyrotropin interactions in the rat | |
dc.type | Article |